Bruker: Industry-Leading Earnings Growth Ahead
Q3 gives greater visibility into improvement of investor sentiment and earnings recovery.
Current Price: $40.05 | Market Cap: $6.06B
Summary of Our Previous Investment Thesis
Before diving into BRKR 0.00%↑ results and why they matter, below is a summary of our investment thesis on the company. We are up 15% since our initial buy report and believe there is still significant upside ahead. For our detailed report, including insights from our meetings with the C-Suite and our financial model, click here: Bruker Equity Research Report